REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

Capital World Investors's Holding History (CIK: 0001422849)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 13,938,589 Value ($000) $35,822 Avg Close — Range —
Q1 2024
Shares 13,945,535 Value ($000) $68,612 Avg Close — Range —
Q4 2023
Shares 11,939,076 Value ($000) $104,944 Avg Close — Range —
Q3 2023
Shares 11,960,820 Value ($000) $137,191 Avg Close — Range —
Q2 2023
Shares 9,574,874 Value ($000) $242,340 Avg Close — Range —
Q1 2023
Shares 10,076,101 Value ($000) $324,551 Avg Close — Range —
Q4 2022
Shares 9,480,156 Value ($000) $175,004 Avg Close — Range —
Q3 2022
Shares 8,048,838 Value ($000) $217,319 Avg Close — Range —
Q2 2022
Shares 4,590,000 Value ($000) $63,434 Avg Close — Range —
Q1 2022
Shares 3,350,000 Value ($000) $65,325 Avg Close — Range —
Q4 2021
Shares 3,712,000 Value ($000) $60,580 Avg Close — Range —
Q3 2021
Shares 2,967,000 Value ($000) $82,661 Avg Close — Range —
Q2 2021
Shares 2,967,000 Value ($000) $87,942 Avg Close — Range —
Q1 2021
Shares 2,571,102 Value ($000) $71,862 Avg Close — Range —
Q4 2020
Shares 2,130,000 Value ($000) $60,364 Avg Close — Range —
Q3 2020
Shares 2,130,000 Value ($000) $53,548 Avg Close — Range —
Q2 2020
Shares 2,130,000 Value ($000) $52,015 Avg Close — Range —
Q1 2020
Shares 2,130,000 Value ($000) $31,524 Avg Close — Range —
Q4 2019
Shares 2,130,000 Value ($000) $34,570 Avg Close — Range —
Q3 2019
Shares 1,685,000 Value ($000) $21,905 Avg Close — Range —
Q2 2019
Shares 1,685,000 Value ($000) $21,854 Avg Close — Range —
Q1 2019
Shares 1,685,000 Value ($000) $26,556 Avg Close — Range —
Q4 2018
Shares 1,225,000 Value ($000) $24,659 Avg Close — Range —
Q3 2018
Shares 1,225,000 Value ($000) $30,441 Avg Close — Range —
Q2 2018
Shares 1,435,000 Value ($000) $39,391 Avg Close — Range —